Using single-dose liposomal amphotericin B for cryptococcal meningitis induction therapy: nurse pearls and practical perspectives.

Wellcome Open Res

Department of Research, Infectious Diseases Institute, College of Health Sciences, Makerere University, Mulago, Kampala, Uganda.

Published: October 2024

AI Article Synopsis

  • A study in Uganda highlights the use of single-dose liposomal amphotericin B (AmBisome) for treating HIV-associated cryptococcal meningitis, showcasing the nursing perspective in its administration.
  • The research details the preparation and administration process, revealing that single-dose AmBisome requires significantly less nursing time than daily doses of conventional amphotericin B.
  • The findings suggest that single-dose liposomal amphotericin B results in fewer side effects and complications, ultimately improving nursing care efficiency in resource-limited settings.

Article Abstract

Background: In Uganda where the burden of HIV-associated cryptococcal meningitis is high, conventional amphotericin B deoxycholate has been standard to manage patients with cryptococcal meningitis in research settings. However, liposomal amphotericin B (AmBisome) is now available via the efforts of UNITAID. We sought to describe our nursing experience using AmBisome within a clinical trial for cryptococcal meningitis.

Methods: We describe the experience of using single-dose 10mg/kg liposomal amphotericin B from the perspective of a research nurse in Uganda. Second, we described the process of preparing and administering amphotericin. Third, we assessed the nursing time required for the administration of daily amphotericin B versus single-dose liposomal amphotericin. Fourth, we discuss the major challenges faced while using liposomal amphotericin B.

Results: We provide estimates for the nursing time required for reconstituting, filtering, diluting and administering liposomal amphotericin B and a visual aid for nursing tasks. Based on five trained nurses, the process of reconstitution and filtration lasts an average of 52 minutes (Range: 40 to 60 minutes), to reconstitute a mean of 11 (range: 8 to 15) 50mg vials (median weight 55kg). Overall, less nursing time was required for single-dose administration than for daily amphotericin B dosing. From a nursing perspective, liposomal amphotericin B was preferable to amphotericin B deoxycholate due to its reduced infusion reactions and other toxicities.

Conclusions: Single-dose liposomal amphotericin B is a better alternative to daily amphotericin B. In addition to less toxicity, nosocomial infections, reduced hospital stay, and the potential for lower hospitalisation costs, the nursing implications should not be discounted. Quality nursing care is a finite resource in low- and middle-income countries, and single-dose amphotericin B reduced the nursing time required for the care of patients with cryptococcal meningitis.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11462120PMC
http://dx.doi.org/10.12688/wellcomeopenres.21450.1DOI Listing

Publication Analysis

Top Keywords

liposomal amphotericin
32
cryptococcal meningitis
16
nursing time
16
time required
16
amphotericin
15
single-dose liposomal
12
daily amphotericin
12
nursing
9
amphotericin deoxycholate
8
patients cryptococcal
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!